Protagen To Apply UNIarray Platform For Biogen Idec To Help Discover Biomarkers In Relapsing Remitting Multiple Sclerosis

Links shared publicly online about this topic.

  • 404
    total visits

Protagen To Apply UNIarray Platform For Biogen Idec To Help Discover Biomarkers In Relapsing Remitting Multiple Sclerosis

medicalnewstoday.com —

Protagen AG, a specialist in in-vitro diagnostics and GMP-compliant protein analysis announced today that they will be using the UNIarray® Platform to help discover biomarkers in relapsing rem

View full resource at medicalnewstoday.com

Tags: Multiple Sclerosis, Protein, Biogen Idec

  • Share

Most Recently Shared on March 29, 2011 at 9:05 am By:

mnt_multiplescl MNT Multiple Scl

Protagen To Apply UNIarray Platform For Biogen Idec To Help Discover Biomarkers In Relapsing Remitting Multiple Sclerosis http://mnt.to/3SQy

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Pharma News MNT Pharma News

Advertisement